Results
|
|
1.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
|
2.
|
Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility. MedStar authors:
Year: 2013
Citation: - Journal of Cardiovascular Magnetic Resonance. 15:10, 2013.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Barbash IM, Chen MY, Eckhaus MA, Faranesh AZ, Halabi M, Hansen MS, Kocaturk O, Lederman RJ, Ratnayaka K, Schenke WH, Slack MC, Wilson JR, Wright VJ
|
|
|
3.
|
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Eurointervention. 8(9):1006-11, 2013 Jan 22.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Deleanu D, Dorobantu M, Hamon M, Niculescu R, Waksman R, Weissman NJ
|
